Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) SHH

28.34

+0.1(+0.35%)

Updated at December 05 01:47PM

Currency In CNY

Valuation

Market Cap11.25B
Enterprise Value8.35B
P/E Ratio21.3
PEG Ratio9.16
Price/Sales Ratio3.23
Price/Book Ratio2.83
Enterprise/Revenue2.89
Enterprise/EBITDA16.65

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.15
Operating Margin0.18

Management Effectiveness

Return On Assets0.11
Return On Equity0.14

Income Statement

Revenue3.73B
Revenue/Share8.74
Gross Profit1.73B
EBITDA622.05M
Net Income528.09M
Diluted EPS1.23

Balance Sheet

Total Cash2.65B
Total Cash/Share6.14
Total Debt247.76M
Total Debt/Equity0.06
Current Ratio5.02
Book Value Per Share10.28

Price History

52-Week Change3.44
52-Week High31.46
52-Week Low23.42
Moving Average 50 Days27.85
Moving Average 200 Days27.27

Statistics

Average Volume7.34M
Shares Outstanding431.05M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.62
Trailing Annual Dividend Yield2.2
Payout Ratio0.01
Last Split Factor13:10
Last Split DateJuly 21, 2015